Ellington Management Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-21,600
| Closed | -$307K | – | 832 |
|
|
2018
Q1 | $307K | Sell |
21,600
-3,100
| -13% | -$44.1K | 0.02% | 571 |
|
|
2017
Q4 | $203K | Buy |
+24,700
| New | +$203K | 0.03% | 477 |
|
|
2017
Q1 | – | Sell |
-29,500
| Closed | -$137K | – | 856 |
|
|
2016
Q4 | $137K | Buy |
+29,500
| New | +$137K | 0.02% | 470 |
|
|
2016
Q3 | – | Sell |
-14,300
| Closed | -$87K | – | 701 |
|
|
2016
Q2 | $87K | Sell |
14,300
-5,100
| -26% | -$31K | 0.12% | 222 |
|
|
2016
Q1 | $165K | Buy |
19,400
+9,051
| +87% | +$77K | 0.07% | 432 |
|
|
2015
Q4 | $123K | Buy |
+10,349
| New | +$123K | 0.04% | 529 |
|
|
2015
Q3 | – | Sell |
-33,200
| Closed | -$551K | – | 895 |
|
|
2015
Q2 | $551K | Buy |
+33,200
| New | +$551K | 0.13% | 216 |
|